Please ensure Javascript is enabled for purposes of website accessibility

Exelixis(EXEL)

Nasdaq Global Select

EXEL
Exelixis Stock Quote
$22.74 $0.33 1.5%
Price as of June 21, 2021, 4:00 p.m. ET View Interactive EXEL Charts

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

Interactive Chart


News & Analysis: Exelixis

The Fool has written over 500 articles on Exelixis.

All

Market Moves

Podcasts

Earnings


Is Exelixis a Buy?

Revenue growth will probably accelerate soon, but it might not be enough.